T. Ozharovskaia

Adjuvantation of an Influenza Hemagglutinin Antigen with TLR4 and NOD2 Agonists Encapsulated in Poly(D,L-Lactide-Co-Glycolide) Nanoparticles Enhances Immunogenicity and Protection against Lethal Influenza Virus Infection in Mice

A. Gintsburg, D. Logunov, B. Naroditsky, 2020, Vaccines.

Обзор кандидатных вакцин для профилактики лихорадки Review of candidate vaccines for the prevention of Lassa fever

D. Logunov, B. Naroditsky, O. Popova, 2021 .

Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus

E. D. Belyaeva, V. Gushchin, I. Grigoriev, 2022, Frontiers in Immunology.

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults

V. Gushchin, A. Gintsburg, D. Logunov, 2021, The Lancet Regional Health - Europe.

Development and characterization of a vector system based on the simian adenovirus type 25

O. Popova, D. Logunov, A. Pochtovyy, 2023, Bulletin of Russian State Medical University.

Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study

V. Gushchin, A. Gintsburg, D. Logunov, 2023, Frontiers in immunology.